AEB 071, with the CAS number 908351-31-5, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain biological pathways, which may be relevant in the treatment of various diseases, including viral infections and certain types of cancer. The compound exhibits specific binding affinity to its target, which is crucial for its mechanism of action. AEB 071 is typically characterized by its molecular structure, which includes functional groups that contribute to its biological activity. Additionally, its solubility, stability, and pharmacokinetic properties are important for its efficacy and safety profile in clinical settings. As with many investigational compounds, ongoing research is essential to fully understand its potential benefits and risks, as well as to establish appropriate dosing regimens and therapeutic applications.

AEB 071

908351-31-5: AEB 071, with the CAS number 908351-31-5, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain biological pathways, which may be relevant in the treatment of various diseases, including viral infections and certain types of cancer. The compound exhibits specific binding affinity to its target, which is crucial for its mechanism of action. AEB 071 is typically characterized by its molecular structure, which includes functional groups that contribute to its biological activity. Additionally, its solubility, stability, and pharmacokinetic properties are important for its efficacy and safety profile in clinical settings. As with many investigational compounds, ongoing research is essential to fully understand its potential benefits and risks, as well as to establish appropriate dosing regimens and therapeutic applications.

<p>Sotrastaurin acetate is a pan-protein kinase C inhibitor. It also has potential immunosuppressive and antineoplastic activities.</p>

CAS 908351-31-5

AEB 071

Sotrastaurin acetate

Ref: TM-T24815